You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 14, October 14, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Medical Practice
 •Health Policy
 •Public Health, Other
 •Screening
 •Drug Therapy
 •Drug Therapy, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Strategies for Preventing HIV Transmission—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: These letters provide additional commentary on the publication by Granich et al1 and accurately point out specific scientific challenges and issues with the universal voluntary HIV testing and immediate treatment for the prevention of HIV transmission known as the test and treat strategy. The purpose of our Commentary was to identify pivotal areas of research that need to be addressed as the scientific community debates and evaluates this strategy.

We agree that much more research is needed to understand the limitations of both ART as prevention and the overall test and treat approach. As the Commentary discussed, these include (1) the relationship between stage of infection and transmission, (2) efficacy of ART in prevention of transmission, (3) development of drug resistance, (4) behavioral disinhibition, (5) the benefit of early treatment to the individual, (6) cost-effectiveness, and (7) the ability to reach target populations and implement annual universal testing. . . . [Full Text of this Article]

Carl W. Dieffenbach, PhD
cdieffenba@niaid.nih.gov

Anthony S. Fauci, MD
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Strategies for Preventing HIV Transmission
David R. Holtgrave
JAMA. 2009;302(14):1530-1531.
EXTRACT | FULL TEXT  

Strategies for Preventing HIV Transmission
Seth Kalichman and Lisa Eaton
JAMA. 2009;302(14):1531.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.